Notice of Intent to Sole Source – 10x Genomics, Inc.
Pre-Solicitation Posted
- Solicitation number
- NOI-OD-26-007025
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department intends to award a sole-source firm fixed price contract to 10x Genomics, Inc. for reagents and consumables supporting the Early Detection of Lung Diseases (EDLI) project, with a close date for comments of July 31, 2026. This procurement is being conducted under FAR Part 13 Simplified Acquisition Procedures (Subpart 13.106-1(b)(1)) for purchases not exceeding the simplified acquisition threshold, with the contracting officer determining that only one source is reasonably available. No formal solicitation document or request for quotations will be issued; this is a notice of intent only. The procurement is exempt from FAR Part 6 competition requirements due to the simplified acquisition threshold application and sole-source justification. Interested parties may submit comments referencing posting number NOI-OD-26-007025 to Ryssa Nix, Contract Specialist, NIH Clinical Center Office of Purchasing and Contracts, at Ryssa.nix@nih.gov prior to the close date. The acquisition is classified under NAICS Code 541715 (Research and Development in the Physical, Engineering, and Life Sciences) and PSC Code 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets).
Notice text
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested.
The National Institutes of Health, Office of Purchasing and Contracts on behalf of the Critical Care Medicine Department intends to award a firm fixed priced contract to 10X Genomics Inc. for the acquisition of reagents and consumables required for the Early Detection of Lung Diseases (EDLI) project.
This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date.
Files
| File | Type | Posted |
|---|---|---|
| NOI to sole source under SAT.docx | DOCX document |
Similar open opportunities
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity